Status:
COMPLETED
Immediate-access Arteriovenous Versus Standard Arteriovenous Grafts in Hemodialysis Patients
Lead Sponsor:
Egyptian Biomedical Research Network
Conditions:
Hemodialysis Access Failure
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Arteriovenous fistulae (AVF) are considered the main access for hemodialysis (HD). Arteriovenous grafts (AVGs) are an alternative access modality in patients with exhausted native venous access. Immed...
Detailed Description
The study aimed to evaluate and compare patency rate and complications of standard arteriovenous grafts (SAVGs) and immediate-access arteriovenous grafts (IAAVGs) in end stage renal disease (ESRD) pat...
Eligibility Criteria
Inclusion
- Adult hemodialysis patients
Exclusion
- Significant cardiorespiratory comorbidities.
- Peripheral vascular disease.
- Pregnancy or lactation.
- Severe bleeding disorders.
Key Trial Info
Start Date :
August 15 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 10 2020
Estimated Enrollment :
477 Patients enrolled
Trial Details
Trial ID
NCT04388397
Start Date
August 15 2017
End Date
April 10 2020
Last Update
July 23 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine, Zagazig University
Zagazig, Egypt
2
Faculty of Medicine
Zagazig, Egypt